TABLE 1.
Overall Price Inflation Rate Comparison
Drug Class | Average WAC (Weighted) % | Average 340B (Weighted) % | Difference % | WAC Difference, Weighted and Unweighted % | 340B Difference, Weighted and Unweighted % | Brand Name | Generic | ||||
---|---|---|---|---|---|---|---|---|---|---|---|
Average WAC % | Average 340B % | Difference % | Average WAC % | Average 340B % | Difference % | ||||||
Overall, all drugs | 14.7 | 10.3 | 4.5 | -1.3 | -0.1 | 23.2 | 15.0 | 8.2 | 10.4 | 5.1 | 5.3 |
Overall, specialty drugs only | 14.1 | 6.4 | 7.8 | 1.5 | -0.5 | 14.5 | 7.8 | 6.7 | 19.6 | 22.9 | -3.3 |
Antiretrovirals | 4.5 | -1.4 | 5.9a | -1.1 | -0.1 | 7.1 | 2.4 | 4.7 | 23.2 | 38.3 | -15.0 |
Antineoplastics | 21.1 | 21.0 | 0.1 | 1.2 | -0.3 | 32.7 | 33.0 | -0.2 | 18.2 | 33.1 | -14.9 |
DMARDs | 19.1 | -3.2 | 22.3 | 7.8 | 5.4 | 21.7 | -1.2 | 22.9 | b | b | b |
Hematopoietic agents | 12.3 | 3.3 | 9.0 | 4.5 | -1.3 | 12.3 | 3.3 | 9.0 | b | b | b |
Interferons | -11.0 | -11.5 | 0.5 | 0.6 | 0.0 | -11.0 | -11.4 | 0.5 | b | b | b |
Immunosuppressive agents | 95.0 | 111.0 | -16.0 | -55.4 | -10.9 | 28.7 | -19.1 | 47.8 | 99.0 | 169.4 | -70.4 |
aP < 0.10.
bNo purchasing records found in dataset.
340B = 340B Drug Discount Program; DMARD = disease-modifying antirheumatic drug; WAC = wholesale acquisition cost.